Supplementary protection
LT - Pirolo[2, 3 -D]pirimidino dariniai, kaip janus kinazės (JAK) inhibitoriai
EN - PYRROLO [2, 3 -D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF JANUS KINASES (JAK)
SPC
| (11) |
Number of the document |
C 2958921 |
| (68) |
Number of the document |
2958921
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2022 502 |
| (22) |
Date of filing the application |
2022-01-26 |
| (41) |
Date of publication of the application |
2022-03-10 |
|
Date of publication of SPC |
2024-03-25 |
| (24) |
Date of coming into effect of SPC |
2034-02-12 |
Applicant
| (71) |
Pfizer Inc.,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
Grantee
| (73) |
Pfizer Inc.,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/21/1593, 2021-12-09
|
Calculated date of expiry of the SPC
| (94) |
2036-12-10 |
Name of the product protected by the basic patent
| (95) |
Abrocitinibas arba farmaciniu požiūriu priimtina jo druska |
